0930 [Dow Jones] STOCK CALL: RBS downgrades Biota (BTA.AU) to Hold from Buy after recent share price rally. Says Australian government's purchase of additional Relenza drugs is positive for Biota, as is news that the national stockpile is now 33% Relenza, up from 20%, with the balance Tamiflu. "This change in mix between Relenza and Tamiflu supports our view that governments are seeking a more equal balance between the two main antiviral drugs, driven by the resistance issues with Tamiflu which have emerged since last year's flu season," RBS says. BTA target price upped to A$1.46 from A$1.41; Biota last traded at A$1.41. (APW)
- Forums
- ASX - By Stock
- BTA
- dow jones
dow jones
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online